Author Nets Seven Retractions

Biochemical Pharmacology pulls papers coauthored by a scientist whose work has been under investigation at MD Anderson Cancer Center.

By | February 22, 2016

WIKIMEDIA, ELKE WETZIG

Biochemical Pharmacology this week retracted seven papers from Bharat Aggarwal, who has studied the physiological effects of curcumin at MD Anderson Cancer Center. As Retraction Watch reported today (February 22), all of the retraction notices state that “the data integrity has become questionable.”

In all seven papers, figures were reused (and, in cases, manipulated to represent different results), according to the retraction notices.

Aggarwal is the subject of an institutional investigation and already has corrections, expressions of concern, and two “withdrawals” to his name.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS